Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia
Adhikari et al. PLoS One, 2012.
Potent Neutralization of Staphylococcal Enterotoxin B In Vivo by Antibodies that Block Binding to the T-Cell Receptor
Chen G, Karauzum H, Long H, Carranza D, Holtsberg FW,
IBT Receives Phase I SBIR grant from NIAID for development of neutralizing monoclonal antibodies against Marburg Virus
IBT in collaboration with the laboratory of Dr. Yuxing Li,
CARB-X FUNDS INTEGRATED BIOTHERAPEUTICS TO EXPAND THE DEVELOPMENT OF ITS STAPHYLOCOCCUS AUREUS VACCINE TO FACILITATE USE IN THE DEVELOPING WORLD
Freeze-dried version of vaccine would boost availability to the world,
IBT Receives Phase II STTR grant from NIAID for development of Novel ISTAb therapeutics for B. anthracis
IBT in collaboration with Dr. Daniel Nelson’s lab at University
IBT Receives Phase II STTR grant from NIAID for development of Novel ISTAb therapeutics for B. anthracis
IBT in collaboration with Dr. Daniel Nelson’s lab at University
Rational Design of Toxoid Vaccine Candidates for Staphylococcus aureus Leukocidin AB (LukAB)
Kailasan S, Kort T, Mukherjee I, Liao GC, Kanipakala T,
Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion
Pleet ML, DeMarino C, Stonier SW, Dye JM, Jacobson S, Aman
Effective Treatment of Staphylococcal Enterotoxin B Aerosol Intoxication in Rhesus Macaques by Using Two Parenterally Administered High-Affinity Monoclonal Antibodies
Verreault D, Ennis J, Whaley K, Killeen SZ, Karauzum H,
Structural basis of broad ebolavirus neutralization by a human survivor antibody
West BR, Wec AZ, Moyer CL, Fusco ML, Ilinykh PA,
